Investments
51Portfolio Exits
4
Want to inform investors similar to Jonathan Milner about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing Jonathan Milner
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Jonathan Milner in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Latest Jonathan Milner News
Sep 20, 2023
gorodenkoff/iStock via Getty Images Abcam (NASDAQ: ABCM ) founder Jonathan Milner is looking at various options to try to regain control of the companyas he opposses the current $24 a share takeover from Danaher (NYSE: DHR ). Abcam ticked up 0.4%. Milner indicated last week in a statement that he plans to request that the company convene a general meeting to replace the company's board, though he hasn't submitted a request yet and it's not clear when he will, according to an Equity Report on Wednesday, which cited a person familiar with the matter. Milner is also discussing the situation with other shareholders. Milner's plan is expected to include keeping Abcam's ( ABCM ) Nasdaq listing while adding back a Main Market listing on the London Stock Exchange, according to the report. Milner's options for Abcam ( ABCM ) may be fairly limited, according to the Equity Report, which cited a lawyer who said that Milner's only real option is to persuade other holders to block the scheme of arrangement. Milner last Thursday said his decision to oppose the Danaher ( DHR ) sale came after he received "extensive" feedback from many holders and analysts that the $24 a share deal "substantially undervalues" Abcam ( ABCM ). Abcam CEO Alan Hirzel on Thursday responded to Milner's plan to vote down the $24 a share takeover. It's "odd to make this choice before you see the facts of the rigorous process that was followed and as you noted in your link above," Hirzel said in a post on LinkedIn i n a response to Milner. "The shareholder circular will make everything clear to shareholders who want the facts."
Jonathan Milner Investments
51 Investments
Jonathan Milner has made 51 investments. Their latest investment was in PharmEnable as part of their Seed VC - II on May 5, 2023.

Jonathan Milner Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
5/19/2023 | Seed VC - II | PharmEnable | $7.5M | No | Arrowfield Capital, Cambridge Enterprise, Jonathan Milner, Martlet Capital, MP Healthcare Venture Management, O2h Ventures, Parkwalk Advisors, Undisclosed Angel Investors, and Wren Capital | 5 |
3/27/2023 | Series B | SolasCure | $13.3M | No | BRAIN, Eva Pharmaa, Jonathan Milner, Seneca Partners, Undisclosed Angel Investors, Undisclosed Venture Investors, and Wealth Club | 5 |
7/6/2022 | Series B - II | Nuclera | $15.5M | Yes | 1 | |
6/14/2022 | Seed VC - IV | |||||
6/9/2022 | Seed VC |
Date | 5/19/2023 | 3/27/2023 | 7/6/2022 | 6/14/2022 | 6/9/2022 |
---|---|---|---|---|---|
Round | Seed VC - II | Series B | Series B - II | Seed VC - IV | Seed VC |
Company | PharmEnable | SolasCure | Nuclera | ||
Amount | $7.5M | $13.3M | $15.5M | ||
New? | No | No | Yes | ||
Co-Investors | Arrowfield Capital, Cambridge Enterprise, Jonathan Milner, Martlet Capital, MP Healthcare Venture Management, O2h Ventures, Parkwalk Advisors, Undisclosed Angel Investors, and Wren Capital | BRAIN, Eva Pharmaa, Jonathan Milner, Seneca Partners, Undisclosed Angel Investors, Undisclosed Venture Investors, and Wealth Club | |||
Sources | 5 | 5 | 1 |
Jonathan Milner Portfolio Exits
4 Portfolio Exits
Jonathan Milner has 4 portfolio exits. Their latest portfolio exit was Valence on May 08, 2023.